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Given that COVID-19 (SARS-CoV-2) has crept into Africa, a major public health crisis
or threat continues to linger on the continent. Many local governments and various
stakeholders have stepped up efforts for early detection and management of COVID-19.
This mini review highlights the current trend in Africa, history and general epidemiological
information on the virus. Current ongoing efforts (e.g., improving testing capacity) and
some effective ways (e.g., intensified surveillance, quick detection, contact tracing,
isolation measures [e.g., quarantine], and social distancing) of preventing and managing
COVID-19 in Africa are described. The review concludes by emphasizing the need for
public health infrastructure development (e.g., laboratories, infectious disease centers,
regional hospitals) and human capacity building for combating COVID-19 and potential
future outbreaks. Additionally, regular public health educational campaigns are urgently
required. Future epidemiological studies to ascertain case fatality and mortality trends
across the continent for policy directions are necessary.
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BACKGROUND
The recent novel coronavirus (COVID-19) pandemic has speedily escalated from China to other
geographical boundaries, including Africa (1, 2). The initial ill-conceived thoughts that Africa is
not conducive for the virus and that Africans have strong immune systems to combat the virus
have been debunked with multiple confirmed cases (3). The swift rise of the pandemic across the
continent is worrisome and has created a serious public health threat. This mini review provides
the history and general epidemiological information on the virus as well as current trends in Africa.
On-going concerted efforts and some effective ways of preventing and managing COVID-19 in
Africa are also described.
HISTORY AND EPIDEMIOLOGICAL INFORMATION ON COVID-19
COVID-19 originated from a group of coronaviruses with RNA genome ranging from 60
nanometer [nm]to 140 nm in diameter with spike-like projections sprouting on a crown-like
feature under the microscope; hence its coveted name coronavirus. Generally, four specific
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coronaviruses, namely HKU1, NL63, 229E, and OC43 have been
found in human beings to cause mild respiratory infection
(4, 5). The pathological characteristics of the current COVID-
19 is similar to the severe acute respiratory syndrome (SARS;
2002–2003) andMiddle East respiratory syndrome (MERS; 2012)
outbreaks. SARS originated through zoonotic transmission of
a novel coronavirus from bats through palm civets in markets
in Guangdong Province, China from 2002 to 2003. This virus
was reported to have affected approximately 8,422 people mainly
in China and Hong Kong, with 916 reported deaths (Case
Fatality Rate [CFR], 17%) (6). MERS also emerged from zoonotic
transmission of a group of viruses that had previously been
detected in bats and cultured from respiratory secretions of
a patient who had died from SARS in 2012 (7). The same
causative organism was previously discovered in clinical trials
from a severe occurrence of acute respiratory disease, which was
first reported in humans in Jordan in 2012 (8, 9). By 2013, 55
laboratory-confirmed cases of MERS were reported in Jordan,
Saudi Arabia, the UK, France, Italy, Germany, and Tunisia (10).
According to Wu and McGoogan (7), all the 3 viral contagions
commonly manifest with fever and cough, which regularly cause
lower respiratory tract disease with poor clinical outcomes related
to old age and primary health conditions. The detection of
infection requires testing of respiratory tract samples (e.g., throat
swabs) through clinical diagnosis which can also be done based
on symptoms, exposures, and chest imaging.
Although early genetic assessment on COVID-19 in China
revealed that the virus was similar to SARS-CoV and MERS-
CoV, scientific evidence in the past months has revealed major
differences between the other outbreaks and characteristics of
COVID-19 (11). Reflecting on available epidemiological data on
the current upsurge, since December 2019 when the first cases
were recorded in Wuhan, China, the virus spread has solely
been driven by human-to-human transmission and not only
as a result of continuous global spillover (11). According to
Heymann et al., COVID-19 reproduces in the upper respiratory
tract and shows minimal symptoms comparable to the other
human coronaviruses that manifest with common colds during
winter. Affected persons create a large amount of virus in the
upper respiratory tract at the onset or prodrome period, go
about normal duties with ease and thus facilitate the spread
of the disease. Comparatively, SARS-CoV transmission did not
readily occur during the prodromal phase when infected persons
were reported mildly ill, and most transmissions were believed
to have happened when infected individuals showed severe
illness. These symptoms made it easier to control SARS-CoV
outbreaks compared to COVID-19 (12). Because the COVID-19
virus is transferred via droplets produced through coughing and
sneezing by persons with notable symptoms and in some cases
from asymptomatic individuals, virtually all ages are susceptible
(13). Infection could be contracted either by inhaling these
tiny microscopic droplets or touching surfaces infected by the
virus and then touching the nose, mouth, eyes and/or face
(13). According to Kampf et al. (14), the virus can stay active
Abbreviations: CFR, Case Fatality Rate; WHO, World Health Organization; IMF,
International Monetary Fund; UNICEF, The United Nations Children’s Fund.
FIGURE 1 | Regional distribution of COVID-19 cases and deaths in Africa as
of 9 am EAT 9 June 2020. This figure is original and based on data from Africa
Center for Disease Control (4).
on surfaces for days in positive atmospheric conditions but
can also be killed within a moment with common antiseptics
or disinfectants.
Reported clinical features of COVID-19 range from acute
respiratory distress syndrome to organ dysfunctions. Common
symptoms also include fever, headache, sore throat, cough,
breathing difficulties, and exhaustion. The infection can progress
within a week to pneumonia, respiratory failure, and death in
different patients (15). According to Singhal (4), the duration
from the onset of symptoms to dyspnea is 5 days, about 7 days
to hospitalization, and development of acute respiratory distress
syndrome (ARDS) in 8 days. Infected persons may require
intensive care admission. Reported recovery may take 2 to 3
weeks. Serious consequences and deaths are more pronounced
in the elderly and persons with co-morbidities (50–75% of fatal
cases) and fatality rate of adult patients ranges from 4 to 11%
whereas overall case fatality rate is estimated to range between
2 and 3% (16, 17).
RECENT COVID-19 TRENDS IN AFRICA
Available data shows that since the first case of COVID-19 was
noted on the 14th February, 2020 in Egypt, a total of 196,254
COVID-19 confirmed cases and 5,341 deaths (Case Fatality Rate
[CFR]: 2.7%) have been reported in 54 African countries as of 9
am EAT 9 June 2020 (18). This figure is an estimation of 2.8% of
all cases reported globally. The proportion of confirmed COVID-
19 cases and deaths reported by African sub-regions in the order
of severity is as follows: Northern region (56,315 cases, 2,291
deaths), Southern region (53,749 cases; 1,108 deaths), Western
region (42,762 cases, 843 deaths), Eastern region (22,740 cases,
662 deaths), and Central region (20,688 cases, 437 deaths, see
Figure 1).
The top three countries worst affected in each region as at
the beginning of 9th June 2020 9 am. EAT stood as follows:
Northern region (Egypt, 35,444 cases, 1,271 deaths; Algeria,
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FIGURE 2 | Top three regional country distribution of COVID-19 cases and deaths in Africa as of 9 am EAT 9 June 2020. This figure is original and based on data from
Africa Center for Disease Control (4).
10,265 confirmed cases, 715 deaths; Morocco, 8,302 cases, 208
deaths), Southern region (South Africa, 50,879 cases, 1,080
deaths; Zambia, 1,200 cases, 10 deaths; Malawi, 443 cases, 4
deaths), Western region (Nigeria, 12,801 cases, 361 deaths;
Ghana, 9,910 cases, 48 deaths; Guinea, 4,221 cases, 23 deaths),
Eastern region (Sudan, 6,242 cases, 372 deaths; Djibouti, 4,278
cases, 31 deaths; Kenya, 2,862, 85 deaths), and Central region
(Cameroon, 8,060 cases, 206 deaths; Democratic Republic of
Congo [DRC], 4,106 cases, 88 deaths; Gabon, 3,247 cases, 21
deaths, see Figure 2) (18).
By 4th August, 2020, a total of 968,020 COVID-19 cases
and 20,612 deaths (CFR: 2%) had been reported in 55 African
countries. The estimation of new COVID-19 cases reported
by region still represented 5% of all cases globally. Below are
the proportions of cases by sub-region: Southern region 65%
(70,318), Northern region 12% (13,016), Western region 9%
(9,638), Eastern region 11% (12,367), and Central region 3%
(3,444). A total of 6 countries accounted for 80% of the new
COVID-19 cases reported within the period in a descending
order: South Africa (59%), Morocco (5%), Algeria (4%), Kenya
(4%), Ghana (4%), and Ethiopia (4%). South Africa (890),
Djibouti (524), Sao Tome and Principe (437), Cape Verde (431),
and Gabon (364) reported the most cumulative COVID-19 cases
per 100,000 in Africa. Reported case fatality rates comparable to
or higher than the global case fatality rate of 4% were noted in 11
African countries; Chad (8%), Sudan (6%), Liberia (6%), Niger
(6%), Egypt (5%), Mali (5%), Burkina Faso (5%), Angola (5%),
Algeria (4%), Sierra Leone (4%), and Tanzania (4%) (19). The
pictorial epidemiological information of COVID-19 per region
as of 31st July, 2020 is captured in Figures 3A–C below (20).
Africa CDC brief report on public health and social measure
implementation indicated that these new cases decreased by 23%
between 28th July and 10th August while new deaths increased
by 11% within the same time period. Total COVID-19 cases
exceeded 1 million for the first time which was cited as the peak
period. The decrease in new cases was attributed to South Africa,
which recorded a 35% decline in newly reported cases, with
data showing that the COVID-19 outbreak might have peaked
in some provinces or districts that were earlier affected by the
virus. Though South Africa still leads in new cases, Morocco,
Kenya and Ethiopia reported rising case counts and new deaths.
The number of tests performed per positive case has remained
low (6 tests per case, see Table 1), suggesting that many cases are
undetected. With the low tests per case ratios in many African
countries (e.g., Algeria, DRC, Egypt, Madagascar, Somalia, South
Sudan and Sudan), denoting poor testing capacity, indications
are that many cases on the continent are less likely to be
detected. Therefore, reported decreases in new cases ought to
be interpreted with caution in many countries. The month of
October saw a slight increase in the number of COVID-19 cases
per 100,000 population. Again, 6 countries accounted for nearly
84% of the new COVID-19 cases; Morocco (31%), South Africa
(18%), Libya (11%), Tunisia (9%), Kenya (7%), and Ethiopia (6%)
by 27th October, 2020 (19).
Given that accurate mortality metrics are essential for
assessing the risks and severity often associated with epidemic
outbreaks like COVID-19, it is crucial to better understand
these associated concepts unambiguously in the estimation of the
current pandemic. The generally used metrics during infectious
disease outbreaks are the case fatality rate (CFR), case fatality
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FIGURE 3 | (A–C) Epidemiological metrics in Africa by 31st July, 2020 (20).
(A) Total cases, recoveries, deaths, and total fatality rate. (B) Case fatality rate
by region. (C). Epidemiologic situation by region.
ratio, and case fatality risk, often used interchangeably. Fatality
rate means a change in deaths per unit time; risk denotes an
individual probability; whereas ratio represents a fraction of
two numbers, usually of populations. Therefore, CFR commonly
represents the ratio of the total estimated number of deaths to
date, D(t), to the estimated number of all confirmed cases to date
Nc (t) or an estimation of the number of deaths to date divided
by the estimated total number of confirmed infected cases to date.
Hence, these figures could be crucial for the estimation of the
COVID-19 disease severity in Africa (21–23).
Conventionally, the reverse transcription polymerase chain
reaction (RT-PCR) and antibody tests are used to confirm
SARS-CoV-2-positive patients based on population data. To
establish accuracy D(t), the number of patients who actually
die of COVID-19 should be appropriately be quantified. For
instance, in Italy, deaths of patients with positive RT-PCR testing
for SARSCoV-2 are reported as COVID-19 deaths and there
could be similar cases across many countries. Therefore, the
central criteria for COVID-19-related deaths as a function of
CFR are currently not clearly defined and may vary from region
to region (24). Other mortality metrics like case fatality risk,
denoted as the probability of death of an individual confirmed
case within a period of time and infection fatality ratios (IFR),
representing the number of deaths to date divided by the number
of all infected individuals add to the confusion. For example,
IFR = D(t)/N(t) requires an estimate of N(t), the number of
total (including unconfirmed) infected individuals [see (21) for
detailed description].
According to Böttcher et al. (21), the further spread of SARS-
CoV-2 in different countries, including those in Africa, makes it
imperative that data on individual cases of death and recovery are
easily stratified according to some specific COVID-19 mortality
indices such as demographic and population heterogeneity,
incubation period, health condition and a patient time of
infection before confirmation is made on mortality estimates.
Additionally, under-testing also confounds accurate estimation
of actual causes of death. For instance, infected individuals
who are untested in a given population consist of an unknown
population which adds to deaths and recovery, and should be
considered as “true” mortalities.
CURRENT COVID-19 EFFORTS IN AFRICA
AND THE WAY FORWARD
The erratic COVID-19 increase and associated deaths in Africa
underscore the essence formuch attention, especially considering
the weak public health systems of most African countries
(19). Given the inherent challenges with general infrastructure
network, poor transportation, neighborhood characteristics (e.g.,
over-crowding related issues) and inadequate trained health
workers in many African countries, pragmatic measures have
targeted preventive measures and effective management of
confirmed cases. In a quick response to the current upsurge
of the pandemic across Africa, the Africa Centers for Disease
Control and Prevention in collaboration with WHO African
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TABLE 1 | Africa COVID-19 Situation between late July and Early August 2020.
Africa Union Region Total Death/Trend 28 July−10 Augusta Total Deaths/Trend 28 July−10 Augusta Countries where Test per
casesb <10
Central 50353 961 Cameroon (9)





Sao Tome & Principe (7)





Northern 177118 7126 Algeria (4)
Egypt (5)
Southern 589343 11093 Eswatini (9)
Malawi (7)
South Africa(6)





aThe total number of cases reported is the number of cases reported since the start of the epidemic. The trend compares new cases and new deaths during 28 July−10 August to
14–27 July to the previous 2-week period (14–27 July). The trend is illustrated in by an arrow icon: a green arrow indicates a decrease >5%, gray is a decrease/increase within 5%, and
red means an increase >5%.
bThe test per case is the number of tests performed per positive case. Countries with a low number of tests per case (<10) may not be testing widely enough to find all cases. Africa
CDC recommends 10–30 tests per case, as a benchmark of adequate testing (19).
Region instituted an Africa Task Force for Novel Coronavirus
that recently launched the “Partnership to Accelerate COVID-
19 Testing (PACT): Test, Trace, Treat in Africa” on 4th June,
2020 (18) to increase testing capacity in member states. PACT
is to offer the needed support as joint continental strategy to
assist member states limit COVID-19 transmission, through
strategies such as staff training. As a result, a team of experts,
community workers, supplies and other resources have been
organized to help test, trace and treat COVID-19 cases in
a timely manner to lessen the effect of the pandemic on
the African continent. Key strategies such as an expansion
of testing to sub-national, research, academic and private
laboratories, increasing human resource capacity, reinforcing
specimen collection, computerization of testing technologies,
and use of pooled sample testing were endorsed (25).
Till date, over million test kits and several thousands
of community health workers have been trained (i.e., with
knowledge and key skills) and deployed. Again, 80 surveillance
rapid responders for COVID-19 have been used in Africa.
Additionally, 625,000 Polymerase Chain Reaction (PCR) tests
have been advanced to 51 member countries and an extra
support of 6,600 GeneXpert cartridges have also been advanced
to three member states (i.e., Comoros, Guinea, Sao Tome) that
have limited or no capacity for PCR testing. There has been
extra supply of pathogen genomics equipment and reagents
to member countries except Egypt (18). Laboratory testing
capacity has increased from two to forty-four countries on
the continent (26). Some countries (e.g., South Africa, Kenya,
Morocco, Ghana, Uganda, Ethiopia) have made steady progress
with testing capacity from a few hundreds to thousands. By
August 2020, nearly 10 million tests have been done on the
continent with 11% positivity rate. However, significant sub-
regional variations exist in the testing capacity, with the Central
Africa region contributing only 3.4% of the total conducted tests,
showing that many countries on the continent are still struggling
to increase testing capacity. Due to the limited testing capacity
across many countries in the African region, pooled sample
testing have been recommended to maximize the use of scarce
test kits and other supplies to facilitate expansion in testing (27).
Considerable efforts are currently ongoing to increase diagnostic
capacity across the continent. For example, Morocco currently
has 44 hospitals with 32 specialized centers that are fully equipped
in response to the pandemic (28). South Africa, Ghana, Nigeria,
Algeria, Senegal, and many African countries have laboratories
for within country testing of COVID-19. Another testing strategy
introduced by some countries (e.g., Ghana) is the Rapid Antibody
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Tests (RAT). RAT uses a lateral flow technology, similar to home
pregnancy tests using nasal swabs for point-of-care diagnosis of
COVID-19 by measuring viral antigens or anti-viral antibodies,
and results obtained within 10min after sampling (29, 30). This
lateral flow kits against COVID-19 have been developed and
are either serology based (detecting host antibodies), or in some
cases, antigen based (detecting specific viral proteins) (27). Many
countries have created isolation and quarantine centers for the
disease, with considerable efforts toward effective contact tracing
of potential contacts with infected persons (31).
Besides all the instituted regional interventions, individual
member states have adopted other mitigating strategies to reduce
the spread of the virus at the national and community level. Since
no specific drugs or vaccines are currently available, and health
systems are overstretched, many affected countries adopted
coercive and non-coercive community interventions with public
engagement (32–35). Within local communities, continuation of
some mitigation strategies to compel people to avoid crowded
places or minimizing crowd sizes and exposure to body contacts
(i.e., physical/social distancing) have been implemented. Such
interventions included controlling essential social gatherings
(e.g., funerals, church services, school attendance, remote
working). Essential activities such as schooling and working were
done with alternate arrangements such as remote or distance
learning. New workplace interventions with work shifts and/
or rotational scheduling to reduce social density against the
propagation of the virus have been employed. Conference calling
and video conferencing helped working staff and tertiary students
adhere to social distancing measures. Other activities such
as attending night clubs, music festivals, cultural celebrations,
and parties were temporarily suspended but have now been
partially lifted with some restrictions (e.g., limited capacity,
wearing of face/nose masks, physical distancing). Entertainment
through virtual concerts with limited performers or artists has
been introduced. Less-essential travels to places with ongoing
transmission have been controlled. Since travel bans might
trigger fear and affect economic life of the people, home
delivery services of essential commodities have been adopted
and still being encouraged, especially in the cities. Symptomatic
individuals have been supported by telephone or online health
consultation. Severe cases have been managed with the provision
of essential life support such as oxygen supplies, and mechanical
ventilators (32–36).
Adopting and compliance to low-cost evidence-based
preventive measures in many African countries where
socioeconomic status of the masses is low have been useful.
For example, the use of locally made face or nose masks with
non-medical cloth made from local fabric has been worn by
people at public places and social gatherings. Senior public
officials have been seen wearing these masks in public places to
serve as an example for the local populace. Alcohol-based hand
rub solutions have also been deployed at strategic locations (e.g.,
transport stations, market places, school/work environment,
supermarkets) without restrictions (36). Continuous creation
of awareness on the preventive and management measures
related to COVD-19 through the media (e.g., radio, television in
local languages and dialects) by public health officials and other
properly trained analogous personnel across individual countries
are still on-going on the African continent.
Protecting local jobs and employees, assets, technology, and
infrastructure of critical sectors of economies have also been
given a priority. African governments have tried protecting
the livelihoods of citizens by preventing unemployment risks
during this period. Private companies have been given financial
assistance, tax and electricity waivers to maintain continuous
production while observing preventive measures. Strategies
to minimize workplace transmission have included daily
pronouncements of being symptom free by all staff members,
and where applicable, requested the screening of staff members.
Therefore, screening everyone at a work place before resumption
of work could be encouraged, especially in higher risk sectors
like the hospitality industry (tourists and hotels), education,
aviation or others with high risk of person-person interactions.
Other areas such as occupational health service delivery should
be crucial for the manufacturing and construction industries by
offering close surveillance on workers and possibly test as well as
facilitate the quarantine of any member with symptoms pending
test results (37).
With the likelihood of reduction in importation during
the current crisis, various local markets on the continent
might significantly depend on domestic production, including
agricultural products. Hence, support for local farmers through
the provision of inputs such as fertilizers, weedicides, pesticides,
outboard motors, fishing nets as well as mass spraying exercises
on local farms could be part of policy interventions for
food security. Local governments should provide social welfare
interventions through the provision of food and other essential
items for personal use, soap and shampoo, to persons living
on the fringes of life during the crisis because of restrictions.
These support mechanisms will help sustain families’ income,
preserve the productive capacity of the working population and
human capital of enterprises as well as the overall economy of
African countries (38). Amidst COVID-19, the entertainment
industry should still be encouraged to use innovative virtual
performances for the masses to help promote their psycho-social
needs. Although country-specific data on health infrastructural
expansion are not readily available, there are reported cases of on-
going developmental projects (e.g., new disease centers, hospitals,
ICUs) in the health sector across many countries (e.g., Morocco,
Senegal, Kenya, Ghana, South Africa, Nigeria) through foreign
aid to increase health facility capacity and recruitment/ training
of healthcare professionals (39).
There are elements of fear, worry and panic about local
transmissions and multiple infections because some individuals
(e.g., internet bloggers, social commentators, opinion leaders,
political officials) are disseminating diverse misinformation or
unsubstantiated malicious information on the virus (37–39).
This ill-advised COVID-19 related misinformation can rapidly
spread the disease and can cause xenophobia on the continent
(40–42). The distress, apprehension and other untruths about
COVID-19 may have serious effects on disease control, and
prior SARS and Ebola outbreaks are clear instances (43, 44).
To manage this challenge, individual governments and media
institutions should engage public health experts to dominate
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the media landscape, especially those from the Centers for
Disease Control to accurately provide relevant COVID-19
information to avoid fear among the general public (45). Mian
and associate reiterated that if health institutions effectively
manage public worries through regular education, the level
of skepticism among populations often stirred by some social
commentators, political opponents, and internet bloggers would
be minimized. Local communities, civil society, media as well
as other support groups are encouraged to provide accurate
COVID-19 information. This goal can be achieved through
strategic partnerships at community level so that authorized
information is distributed (46).
Negative attitudes of some persons toward formulated
public guidelines could be minimized by regular community
monitoring by local task force teams. There is also the need to
prioritize some special groups (e.g., the disabled, incarcerated
persons, people living on the streets, illiterates and other
marginalized groups [e.g., mentally challenged persons]) on
the continent that are often left to live on the fringes during
developmental issues. Considering the ailing health systems of
most African countries, existing structures are unable to serve
the needs of these groups adequately. Admittedly, these groups
could also be at serious risk in times of pandemic outbreaks
such as the COVID-19 due to their vulnerability. The COVID-
19 precautionary messages, both text and audio, ought to be
translated into all predominantly spoken local languages across
the continent. The earlier audio-visual aids and braille versions
of all precautionary measures are adopted, the better it will be for
the continent to ensure the safety of these groups.
CONCLUSIONS
Many countries in Africa have instituted interventions to curtail
COVID-19. However, these measures are not without challenges.
Many health care systems in Africa are woefully inadequate
characterized by under-resourced facilities. The World Health
Organization (WHO) and donor agencies should partner local
governments in the African region to establish new health
infrastructure (e.g., referral laboratories) and equip existing
ones with appropriate materials and requisite health logistics.
African governments should adopt appropriate context-specific
strategies that fit their contextual and geopolitical situations. To
effectively deal with public health challenges like the current
outbreak, training more human capacities in areas such as
surveillance, rapid epidemic response, diagnostic testing, and
crisis management should be compelling for governments as
well as their private sector and international partners (e.g.,
WHO, UNICEF, IMF, World Bank). Besides, collaborating with
local stakeholder groups (e.g., telecommunication companies-
radio/television stations, religious and educational institutions)
for regular public health educational campaigns to support the
dissemination of COVID-19 information regarding prevention
and control practices and creating awareness at the grassroots
level are still required.
Although case-fatality rate (CFR) for COVID-19 on the
African continent is lower than the global estimation, the
scientific evidence about the virus could be inconclusive and may
still evolve. Therefore, it is more likely other potential parameters
(e.g., population heterogeneity- density, age distribution) may
be unraveled in the months to come relative to other non-
communicable diseases. It is imperative that compromised
healthcare systems, including inadequate human capacity in
Africa effectively should be managed effectively to overcome
the current outbreak as well as future unforeseen ones. Future
epidemiological studies to ascertain case fatality and mortality
trends are warranted for policy directions.
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